USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.81% | -321.46% | -20.07% | -139.85% | -161.49% |
| Total Depreciation and Amortization | 1.05% | -4.52% | -4.45% | 74.81% | 72.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.62% | 973.85% | 18.45% | 561.71% | 24.09% |
| Change in Net Operating Assets | 138.59% | 392.92% | -45.94% | -230.38% | -227.18% |
| Cash from Operations | 710.15% | 90.86% | -36.97% | -158.60% | -106.64% |
| Capital Expenditure | -10.13% | 37.24% | 5.64% | -55.11% | -33.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -206.01% | -- | -- | -- |
| Cash from Investing | -10.04% | 2.52% | 32.98% | 100.54% | -36.78% |
| Total Debt Issued | -- | 212.50% | -- | -30.43% | 100.00% |
| Total Debt Repaid | -- | 22.76% | -- | -33,433.33% | -100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 8.00% | 99.83% | 84.34% | 24.32% | -26.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 90.60% | 63.67% | 74.83% | -41.33% | -1,155.13% |
| Foreign Exchange rate Adjustments | 1,133.33% | -73.41% | 24.62% | 128.11% | -96.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 273.93% | 120.72% | 306.31% | 107.14% | -118.34% |